BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26068067)

  • 1. De novo mutations in PLXND1 and REV3L cause Möbius syndrome.
    Tomas-Roca L; Tsaalbi-Shtylik A; Jansen JG; Singh MK; Epstein JA; Altunoglu U; Verzijl H; Soria L; van Beusekom E; Roscioli T; Iqbal Z; Gilissen C; Hoischen A; de Brouwer APM; Erasmus C; Schubert D; Brunner H; Pérez Aytés A; Marin F; Aroca P; Kayserili H; Carta A; de Wind N; Padberg GW; van Bokhoven H
    Nat Commun; 2015 Jun; 6():7199. PubMed ID: 26068067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiopathologic Bases of Moebius Syndrome: Combining Genetic, Vascular, and Teratogenic Theories.
    López Gutierrez D; Luna López I; Medina Mata BA; Moreno Castro S; García Rangel FY
    Pediatr Neurol; 2024 Apr; 153():1-10. PubMed ID: 38306744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental delay with hypotrophy associated with homozygous functionally relevant REV3L variant.
    Halas A; Fijak-Moskal J; Kuberska R; Murcia Pienkowski V; Kaniak-Golik A; Pollak A; Poznanski J; Rydzanicz M; Bik-Multanowski M; Sledziewska-Gojska E; Płoski R
    J Mol Med (Berl); 2021 Mar; 99(3):415-423. PubMed ID: 33474647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multigenic truncation of the semaphorin-plexin pathway by a germline chromothriptic rearrangement associated with Moebius syndrome.
    Nazaryan-Petersen L; Oliveira IR; Mehrjouy MM; Mendez JMM; Bak M; Bugge M; Kalscheuer VM; Bache I; Hancks DC; Tommerup N
    Hum Mutat; 2019 Aug; 40(8):1057-1062. PubMed ID: 31033088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poland-Möbius syndrome: a case report implicating a novel mutation of the PLXND1 gene and literature review.
    Glass GE; Mohammedali S; Sivakumar B; Stotland MA; Abdulkader F; Prosser DO; Love DR
    BMC Pediatr; 2022 Dec; 22(1):745. PubMed ID: 36581828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An exome sequencing study of Moebius syndrome including atypical cases reveals an individual with CFEOM3A and a
    Patel RM; Liu D; Gonzaga-Jauregui C; Jhangiani S; Lu JT; Sutton VR; Fernbach SD; Azamian M; White L; Edmond JC; Paysse EA; Belmont JW; Muzny D; Lupski JR; Gibbs RA; Lewis RA; Lee BH; Lalani SR; Campeau PM
    Cold Spring Harb Mol Case Stud; 2017 Mar; 3(2):a000984. PubMed ID: 28299356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Polymerase Activity of Mammalian DNA Pol ζ Is Specifically Required for Cell and Embryonic Viability.
    Lange SS; Tomida J; Boulware KS; Bhetawal S; Wood RD
    PLoS Genet; 2016 Jan; 12(1):e1005759. PubMed ID: 26727495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single aspartate mutation in the conserved catalytic site of Rev3L generates a hypomorphic phenotype in vivo and in vitro.
    Fritzen R; Delbos F; De Smet A; Palancade B; Canman CE; Aoufouchi S; Weill JC; Reynaud CA; Storck S
    DNA Repair (Amst); 2016 Oct; 46():37-46. PubMed ID: 27481099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence analysis of the PLEXIN-D1 gene in Möbius syndrome patients.
    van der Zwaag B; Verzijl HT; Wichers KH; Beltran-Valero de Bernabe D; Brunner HG; van Bokhoven H; Padberg GW
    Pediatr Neurol; 2004 Aug; 31(2):114-8. PubMed ID: 15301830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exome sequencing reveals recurrent REV3L mutations in cisplatin-resistant squamous cell carcinoma of head and neck.
    Huang KK; Jang KW; Kim S; Kim HS; Kim SM; Kwon HJ; Kim HR; Yun HJ; Ahn MJ; Park KU; Ramnarayanan K; McPherson JR; Zhang S; Rhee JK; Vettore AL; Das K; Ishimoto T; Kim JH; Koh YW; Kim SH; Choi EC; Teh BT; Rozen SG; Kim TM; Tan P; Cho BC
    Sci Rep; 2016 Jan; 6():19552. PubMed ID: 26790612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics and whole exome sequencing results of patients with Möbius syndrome].
    Ma Q; Jia HY; Chang QL; Wang YD; Liang Y; Wang D; Zhang RR; Jiao YH
    Zhonghua Yan Ke Za Zhi; 2022 Jun; 58(6):441-447. PubMed ID: 35692026
    [No Abstract]   [Full Text] [Related]  

  • 12. Case report: Identification of a novel variant p.Gly215Arg in the
    Manso-Bazús C; Spataro N; Gabau E; Beltrán-Salazar VP; Trujillo-Quintero JP; Capdevila N; Brunet-Vega A; Baena N; Jeyaprakash AA; Martinez-Glez V; Ruiz A
    Front Genet; 2024; 15():1291063. PubMed ID: 38356699
    [No Abstract]   [Full Text] [Related]  

  • 13. Mutant POLQ and POLZ/REV3L DNA polymerases may contribute to the favorable survival of patients with tumors with POLE mutations outside the exonuclease domain.
    Huang F; Tanaka H; Knudsen BS; Rutgers JK
    BMC Med Genet; 2020 Aug; 21(1):167. PubMed ID: 32838755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APIM-Mediated REV3L⁻PCNA Interaction Important for Error Free TLS Over UV-Induced DNA Lesions in Human Cells.
    Ræder SB; Nepal A; Bjørås KØ; Seelinger M; Kolve RS; Nedal A; Müller R; Otterlei M
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30597836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining the genetics of congenital facial paralysis--a closer look at Moebius syndrome.
    Kadakia S; Helman SN; Schwedhelm T; Saman M; Azizzadeh B
    Oral Maxillofac Surg; 2015 Jun; 19(2):109-16. PubMed ID: 25663568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. REV3L modulates cisplatin sensitivity of non-small cell lung cancer H1299 cells.
    Wang W; Sheng W; Yu C; Cao J; Zhou J; Wu J; Zhang H; Zhang S
    Oncol Rep; 2015 Sep; 34(3):1460-8. PubMed ID: 26165320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new hereditary congenital facial palsy case supports arg5 in HOX-DNA binding domain as possible hot spot for mutations.
    Uyguner ZO; Toksoy G; Altunoglu U; Ozgur H; Basaran S; Kayserili H
    Eur J Med Genet; 2015; 58(6-7):358-63. PubMed ID: 26007620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. REV3L 3'UTR 460 T>C polymorphism in microRNA target sites contributes to lung cancer susceptibility.
    Zhang S; Chen H; Zhao X; Cao J; Tong J; Lu J; Wu W; Shen H; Wei Q; Lu D
    Oncogene; 2013 Jan; 32(2):242-50. PubMed ID: 22349819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of DNA polymerase zeta enhances spontaneous tumorigenesis.
    Wittschieben JP; Patil V; Glushets V; Robinson LJ; Kusewitt DF; Wood RD
    Cancer Res; 2010 Apr; 70(7):2770-8. PubMed ID: 20215524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. REV3L, the catalytic subunit of DNA polymerase ζ, is involved in the progression and chemoresistance of esophageal squamous cell carcinoma.
    Zhu X; Zou S; Zhou J; Zhu H; Zhang S; Shang Z; Ding WQ; Wu J; Chen Y
    Oncol Rep; 2016 Mar; 35(3):1664-70. PubMed ID: 26752104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.